High Prevalence of Mucosa-Associated E. coli Producing Cyclomodulin and Genotoxin in Colon Cancer

Cited by (538)

Items 301–400 of 538

1. Intratumoural pks Escherichia coli is associated with risk of metachronous colorectal cancer and adenoma development in people with Lynch syndrome
   Yen Lin Chu, Peter Georgeson, Mark Clendenning, Khalid Mahmood, Romy Walker, Julia Como, Sharelle L. Joseland, Susan Preston, Toni Rice, Brigid Mary Lynch et al. · 2025 · EBioMedicine
2. Colorectal cancer biofilm composition reveals distinct bacterial species signature
   Manish Kushwaha, Nishu Dalal, Shubham Chaudhary, Anam Ahmed, Govind Kumar Makharia, Akhilesh Kumar Singh, Anil Kumar · 2025 · Applied Microbiology and Biotechnology
3. Cytotoxic necrotizing factor 1 hinders colon tumorigenesis induced by colibactin-producing Escherichia coli in Apc Min/+ mice
   Héloïse Chat, Guillaume Dalmasso, Catherine Godfraind, Virginie Bonnin, Racha Beyrouthy, Mathilde Bonnet, Nicolas Barnich, Amel Mettouchi, Emmanuel Lemichez, Richard Bonnet et al. · 2023 · Gut Microbes
4. Expanding germ-organ theory: Understanding non-communicable diseases through enterobacterial translocation
   Seenivasan Boopathi, P. Snega Priya, B. Haridevamuthu, S.P. Ramya Ranjan Nayak, Munisamy Chandrasekar, Jesu Arockiaraj, Ai‐Qun Jia · 2023 · Pharmacological Research
5. Targeting bacterial metabolites in tumor for cancer therapy: An alternative approach for targeting tumor-associated bacteria
   Guofeng Ji, Jingjing Zhao, Xinghui Si, Wantong Song · 2024 · Advanced Drug Delivery Reviews
6. Microbiome Dysbiosis, Dietary Intake and Lifestyle-Associated Factors Involve in Epigenetic Modulations in Colorectal Cancer: A Narrative Review
   Genevieve Kwao‐Zigah, Antoinette Bediako‐Bowan, Pius Agyenim Boateng, Gloria Kezia Aryee, Stacy Magdalene Abbang, Gabriel Atampugre Atampugbire, Osbourne Quaye, Emmanuel Ayitey Tagoe · 2024 · Cancer Control
7. Microbiome's Universe: Impact on health, disease and cancer treatment
   Zsuzsánna Réthi‐Nagy, Szilvia Juhász · 2024 · Journal of Biotechnology
8. Genotoxic Escherichia coli Strains Encoding Colibactin, Cytolethal Distending Toxin, and Cytotoxic Necrotizing Factor in Laboratory Rats
   Susanna A. Kurnick, Anthony J. Mannion, Yan Feng, Carolyn M. Madden, Paul Chamberlain, James G. Fox · 2019 · Comparative Medicine
9. Intestinal colonization of genotoxic Escherichia coli strains encoding colibactin and cytotoxic necrotizing factor in small mammal pets
   Niora J. Fabian, Anthony J. Mannion, Yan Feng, Carolyn M. Madden, James G. Fox · 2019 · Veterinary Microbiology
10. Human Gut Microbiota–associated Gastrointestinal Malignancies: A Comprehensive Review
    Apurva A. Bonde, Sean Daly, Julia Kirsten, Sainath Kondapaneni, Vincent M. Mellnick, Christine O. Menias, Venkata Subbiah Katabathina · 2021 · Radiographics
11. Western lifestyle as a driver of dysbiosis in colorectal cancer
    Nora J. Foegeding, Zachary Jones, Mariana Xavier Byndloss · 2021 · Disease Models & Mechanisms
12. Gut Microbiota in Colorectal Cancer: Associations, Mechanisms, and Clinical Approaches
    Cayetano Pleguezuelos‐Manzano, Jens Puschhof, Hans C. Clevers · 2021 · Annual Review of Cancer Biology
13. Phenotypicand Genotypic Characterization of Clinical Isolates of Intracellular Adherent–Invasive Escherichia coli Among Different Stages, Family History, and Treated Colorectal Cancer Patients in Iran
    Razie Kamali Dolatabadi, Hossein Fazeli, Mohammad Hassan Emami, Vajihe Karbasizade, Fatemeh Maghool, Alireza Fahim, Hojatollah Rahimi · 2022 · Frontiers in Cellular and Infection Microbiology
14. Bladder Cancer and the Urinary Microbiome—New Insights and Future Directions: A Review
    Angela E. Russo, Areeba Memon, Shahid Sattar Ahmed · 2024 · Clinical Genitourinary Cancer
15. The Gut Microbiome Correlated to Chemotherapy Efficacy in Diffuse Large B-Cell Lymphoma Patients
    Zhuofan Xu, Yuan Li, Yan Zhang, Wei Zhang, Chong Wei, Wei Wang, Danqing Zhao, Daobin Zhou, Jingnan Li · 2024 · Hematology Reports
16. The Uropathogenic Specific Protein Gene usp from Escherichia coli and Salmonella bongori is a Novel Member of the TyrR and H-NS Regulons
    Erik Rihtar, Darja Žgur Bertok, Zdravko Podlesek · 2020 · Microorganisms
17. The Role of Escherichia coli in the Development and Progression of Cancer
    2017 · ARC Journal of Cancer Science
18. From promotion to management: The wide impact of bacteria on cancer and its treatment
    Ernesto Peréz-Chanona, Christian Jobin · 2014 · BioEssays
19. Genomic characterization of Escherichia coli with a polyketide synthase (pks) island isolated from ulcerative colitis patients
    Chao Lv, Mohd Abdullah, Chun‐Li Su, Weiye Chen, Nan Zhou, Zile Cheng, Yiwen Chen, Min Li, Kenneth William Simpson, Ahmed M. Elsaadi et al. · 2025 · BMC Genomics
20. The gut microbiome in colorectal cancer: mechanisms of carcinogenesis and emerging microbiota-targeted therapies
    Y Li, Xingyu Shen, Deqiang Wang, Kang Sun · 2026 · Discover Oncology
21. Determination of biomarkers associated with neoadjuvant treatment response focusing on colibactin-producing Escherichia coli in patients with mid or low rectal cancer: a prospective clinical study protocol (MICARE)
    Christophe Taoum, Guillaume Carrier, Marta Jarlier, Gwenaëlle Roche, Johan Gagnière, Catherine Fiess, Hélène de Forges, Caroline Chevarin, Pierre‐Emmanuel Colombo, Nicolas Barnich et al. · 2022 · BMJ Open
22. Gut microbiome in cancer immunotherapy: Current trends, translational challenges and future possibilities
    Pratibha Pandey, Fahad Khan · 2023 · Biochimica et Biophysica Acta (BBA) - General Subjects
23. Colibactin-induced damage in bacteria is cell contact independent
    Emily Lowry, Amir Mitchell · 2024 · mBio
24. Seaweeds as emerging functional foods and therapeutics for colorectal cancer management
    Ashwini Gengatharan, Nur-Vaizura Mohamad, Che Nur Mazadillina Che Zahari, Ramya Vijayakumar · 2025 · Discover Food
25. Diffusely Adherent Escherichia coli
    Mario Meza-Segura, Teresa Estrada‐García · 2016 · Springer eBooks
26. E. coli Sepsis: Red Flag for Colon Carcinoma—A Case Report and Review of the Literature
    Hiren G. Patel, Seme Tabassum, Sohail N. Shaikh · 2017 · Case Reports in Gastrointestinal Medicine
27. Structural Basis for the Interactions of the Colibactin Resistance Gene Product ClbS with DNA
    Prabhanshu Tripathi, Steven D. Bruner · 2021 · Biochemistry
28. Pathobiont hypnotises enterocytes to promote tumour development
    Benoît Chassaing, Andrew T. Gewirtz · 2014 · Gut
29. Preclinical and clinical evidence of the association of colibactin-producing Escherichia coli with anxiety and depression in colon cancer
    Fabien Rondepierre, Maëva Meynier, Johan Gagnière, Vincent Deneuvy, Anissa Deneuvy, Gwenaëlle Roche, Elodie Baudu, Bruno Pereira, Richard Bonnet, Nicolas Barnich et al. · 2024 · World Journal of Gastroenterology
30. New therapeutics from Nature: The odd case of the bacterial cytotoxic necrotizing factor 1
    Zaira Maroccia, Stefano Loizzo, Sara Travaglione, Claudio Frank, Alessia Fabbri, Carla Fiorentini · 2018 · Biomedicine & Pharmacotherapy
31. Determination of virulence determinants of Escherichia coli strains isolated from patients with colorectal cancer compared to the healthy subjects.
    Omid Zarei, Mohammad Reza Arabestani, Amir Majlesi, Younes Mohammadi, Mohammad Yousef Alikhani · 2019 · Gastroenterology and hepatology from bed to bench.
32. pks+ Escherichia coli more prevalent in benign than malignant colorectal tumors
    Carmina V. Tolentino, Ana Maria Cariño, Kin Israel Notarte, Imee Macaranas, Allan Fellizar, Rock Christian Tomas, Lara Mae Angeles, Lorenzo Abanilla, Antonio Lim, Ma. Kristina Carmela Aguilar et al. · 2021 · Molecular Biology Reports
33. Emerging evidence on the role of breast microbiota on the development of breast cancer in high-risk patients
    Silvia Actis, Massimiliano Cazzaniga, Valentina Elisabetta Bounous, Marta D’Alonzo, Roberta Rosso, Francesca Accomasso, Carola Minella, Nicoletta Biglia · 2023 · Carcinogenesis
34. Exploring micronutrients and microbiome synergy: pioneering new paths in cancer therapy
    Kartik Bhatnagar, Kanupriya Jha, Nishu Dalal, Ninad Patki, Garima Gupta, Amit Kumar, Anil Kumar, Sarika Chaudhary · 2024 · Frontiers in Immunology
35. CRCpred: An AI-ML tool for colorectal cancer prediction using gut microbiome
    Deepika Pateriya, Aditya Sanjay Malwe, Vineet K. Sharma · 2025 · Computers in Biology and Medicine
36. Surface expression of antitoxin on engineered bacteria neutralizes genotoxic colibactin in the gut
    Shaobo Yang, Zongqi Wang, Chengyuan Fang, Mengdi Yang, Saleh Khawaled, Shanna Lillian Bonanno, Neel S. Joshi, Yun Wei, Ke Zhang, Valeria Márquez-Pellegrin et al. · 2025 · Nature Microbiology
37. Prevalence of Cyclomodulin-Positive E. coli and Klebsiella spp. Strains in Mexican Patients with Colon Diseases and Antimicrobial Resistance
    Adrián Canizalez‐Román, Juan E. Reina-Reyes, Uriel Alberto Angulo Zamudio, Eloy E. Geminiano-Martínez, Antonio F. Flores-Carrillo, Rolando R. García-Matus, Norma Valencia-Mijares, Nidia Maribel León-Sicairos, Jorge A. Velazquez-Roman, Francisco A. Martínez‐Villa et al. · 2021 · Pathogens
38. The microbiome, its molecular mechanisms and its potential as a therapeutic strategy against colorectal carcinogenesis (Review)
    Stella Baliou, Maria Adamaki, Demetrios A. Spandidos, Anthony M. Kyriakopoulos, Ioannis Christodoulou, Vassilis C. Zoumpourlis · 2018 · World Academy of Sciences Journal
39. Replication of Crohn’s Disease Mucosal E. coli Isolates inside Macrophages Correlates with Resistance to Superoxide and Is Dependent on Macrophage NF-kappa B Activation
    Ahmed Tawfik, Paul Knight, Carrie A. Duckworth, David Mark Pritchard, Jonathan Michael Rhodes, Barry James Campbell · 2019 · Pathogens
40. Cancer Microbiome; Opportunities and Challenges
    Srivathsa Nallanchakravarthula, Narayanappa Amruta, Chitteti Ramamurthy · 2020 · Endocrine Metabolic & Immune Disorders - Drug Targets
41. Characterization of Escherichia coli harboring colibactin genes (clb) isolated from beef production and processing systems
    Manita Guragain, John William Schmidt, Norasak Kalchayanand, Aaron M. Dickey, Joseph M. Bosilevac · 2022 · Scientific Reports
42. The Association Between the Urinary Microbiome and Bladder Cancer
    Ahmed Aly Hussein, Gary J. Smith, Khurshid A. Guru · 2022 · Urologic Clinics of North America
43. Human Intestinal Organoids and Microphysiological Systems for Modeling Radiotoxicity and Assessing Radioprotective Agents
    Eloïse Bouges, Charlotte Segers, Natalie Leys, Sarah Lebeer, Jianbo Zhang, Felice Mastroleo · 2023 · Cancers
44. The impact of intestinal and mammary microbiomes on breast cancer development: A review on the microbiota and oestrobolome roles in tumour microenvironments
    Sofia Rozani, Panagis M. Lykoudis · 2024 · The American Journal of Surgery
45. The interactions between gut microbiota and Chinese herbal medicine in colorectal cancer
    Xinxin Hou, Xinyi Li, Wanqing Chen, Weikang Zhu, Haidong Guo, Ling Zhao · 2025 · Acupuncture and Herbal Medicine
46. Controlled Complexity: Optimized Systems to Study the Role of the Gut Microbiome in Host Physiology
    Robert W. P. Glowacki, Morgan J. Engelhart, Philip P. Ahern · 2021 · Frontiers in Microbiology
47. Customizing Host Chromatin: a Bacterial Tale
    Michael G. Connor, Laurence Arbibe, Mélanie Anne Hamon · 2019 · Microbiology Spectrum
48. Cnf1 Variants Endowed with the Ability to Cross the Blood–Brain Barrier: A New Potential Therapeutic Strategy for Glioblastoma
    Andrea Colarusso, Zaira Maroccia, Ermenegilda Parrilli, Elena Angela Pia Germinario, Andrea Fortuna, Stefano Loizzo, Laura Ricceri, Maria Luisa Tutino, Carla Fiorentini, Alessia Fabbri · 2020 · Toxins
49. Colibactin DNA damage signature indicates causative role in colorectal cancer
    Paulina J. Dziubańska-Kusibab, Hilmar Berger, Federica Battistini, Britta A. M. Bouwman, Amina Iftekhar, Riku Katainen, Nicola Crosetto, Modesto Orozco, Lauri A. Aaltonen, Thomas F. Meyer · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
50. Association between Bacteroides fragilis and Fusobacterium nucleatum infection and colorectal cancer in Vietnamese patients
    Truong Nguyen Duy, Hoang Le Huy, Dao Thanh Quyen, Hoai Ngo Thi, Hanh Ngo Thi Minh, Manh Nguyen Dang, Lê Hữu Song, Ngo Tat Trung · 2024 · Anaerobe
51. Microbiota-associated mechanisms in colorectal cancer
    Adriana González, Asier Fullaondo, Adrián Odriozola · 2024 · Advances in genetics
52. Registered report: Intestinal inflammation targets cancer-inducing activity of the microbiota
    Kate Eaton, Wanwan Yang, Reproducibility Project: Cancer Biology · 2015 · eLife
53. Genetic heterogeneity of colorectal cancer and the microbiome
    M. A. Senchukova · 2023 · World Journal of Gastrointestinal Oncology
54. Interaction between intestinal flora and gastric cancer in tumor microenvironment
    Mingjin Yang · 2024 · Frontiers in Oncology
55. Oral Microbiome: Potential Link to Systemic Diseases and Oral Cancer
    Adrian A. Vasquez, Jeffrey L. Ram, Milad S. Qazazi, Jun Sun, Ikuko Kato · 2018 · Springer eBooks
56. Microbiome and gastrointestinal malignancies
    Ibrahim M. Sayed, Haidi Karam‐Allah Ramadan, Mohamed A. El‐Mokhtar, Lobna Abdel-Wahid · 2021 · Current Opinion in Physiology
57. Cyclomodulins and Hemolysis in E. coli as Potential Low-Cost Non-Invasive Biomarkers for Colorectal Cancer Screening
    Kristýna Mezerová, Lubomír Starý, Pavel Zbořil, I Klementa, Martin Stašek, Petr Špička, Pavel Skalický, Vladislav Raclavský · 2021 · Life
58. Whole-Transcriptome Sequencing Reveals Characteristics of Cancer Microbiome in Korean Patients with GI Tract Cancer: Fusobacterium nucleatum as a Therapeutic Target
    Hyeok Ahn, Kyungchan Min, Eulgi Lee, Hyun Kim, Sujeong Kim, Yun-Jae Kim, Gihyeon Kim, Beomki Cho, Chanyeong Jeong, Yeongmin Kim et al. · 2022 · Microorganisms
59. Photoactivated Colibactin Probes Induce Cellular DNA Damage
    Lindon W. K. Moodie, Madlen Hubert, Xin Mei Zhou, Michael F. Albers, Richard Lundmark, Sjoerd Wanrooij, Christian Hedberg · 2018 · Angewandte Chemie International Edition
60. Nanostructured Thin Coatings Containing Anthriscus sylvestris Extract with Dual Bioactivity
    Irina Neguț, Valentina Grumezescu, Alexandru Mihai Grumezescu, Alexandra Cătălina Bîrcă, Alina Maria Holban, Iuliana Urzică, Sorin Marius Avramescu, Bianca Gălățeanu, Ariana Hudiță · 2020 · Molecules
61. Colibactin leads to a bacteria-specific mutation pattern and self-inflicted DNA damage
    Emily Lowry, Yiqing Wang, Tal Dagan, Amir Mitchell · 2024 · Genome Research
62. The Anti- and Pro-Tumorigenic Role of Microbiota and Its Role in Anticancer Therapeutic Strategies
    Giulia Greco, Sabrina Donati Zeppa, Deborah Agostini, Giuseppe Attisani, Claudio Stefanelli, Fabio Ferrini, Piero Sestili, Carmela Fimognari · 2022 · Cancers
63. Small Animals Gut Microbiome and Its Relationship with Cancer
    T. M. Ferrarias, Andreia Alexandra Ferreira Santos · 2021 · IntechOpen eBooks
64. ATG16L1 in myeloid cells limits colorectal tumor growth in Apc Min/+ mice infected with colibactin-producing Escherichia coli via decreasing inflammasome activation
    Laurène Salesse, Angéline Duval, Pierre Sauvanet, Alison Da Silva, Nicolas Barnich, Catherine Godfraind, Guillaume Dalmasso, Hang Thi Thu Nguyen · 2024 · Autophagy
65. Preventive Methods for Colorectal Cancer Through Dietary Interventions: A Focus on Gut Microbiota Modulation
    Yujie Zhong, Zhijia Liu, Yanfei Wang, Shengbao Cai, Zhu Qiao, Xiaosong Hu, Tao Wang, Junjie Yi · 2024 · Food Reviews International
66. Characterization of genotoxin-encoding Escherichia coli isolated from specific-pathogen free cats with impaired fertility
    Anthony J. Mannion, Whitney K. McGee, Yan Feng, Zeli Shen, Ellen M. Buckley, JoAnn Dzink-Fox, James G. Fox · 2022 · Veterinary Microbiology
67. Roles of Gut Microbiota in Colorectal Carcinogenesis Providing a Perspective for Early Diagnosis and Treatment
    Mohammad Ahangarzadeh Rezaee, Roghayeh Nouri, Alka Hasani, Mohammad Asgharzadeh, Fatemeh Yeganeh Sefidan, Fatemeh Hemmati · 2022 · Current Pharmaceutical Biotechnology
68. Structure and function of prodrug-activating peptidases
    J. Velilla, Grace E. Kenney, Rachelle Gaudet · 2022 · Biochimie
69. Escherichia coli from biopsies differ in virulence genes between patients with colorectal neoplasia and healthy controls
    Juraj Bosák, Darina Kohoutová, Matěj Hrala, Jitka Křenová, Paula Morávková, Stanislav Rejchrt, Jan Bureš, David Šmajs · 2023 · Frontiers in Microbiology
70. Targeted depletion of pks + bacteria from a fecal microbiota using specific antibodies
    Aitor Blanco‐Míguez, Raquel Marcos-Fernández, Lucía Guadamuro, Florentino Fdez‐Riverola, Joaquín Cubiella, Anália Maria Garcia Lourenço, Abelardo Margollés, Borja Sánchez · 2023 · mSystems
71. Are we any closer to screening for colorectal cancer using microbial markers?A critical review
    Lubomír Starý, Kristýna Mezerová, Pavel Skalický, Pavel Zbořil, Vladislav Raclavský · 2017 · Biomedical Papers
72. A Probiotic Friend
    Dubbert, Silke, von Bünau, Rudolf · 2021 · mSphere
73. L-serine promotes pro-carcinogenic effects of colibactin-producing E. coli
    A. Devaux, Romain Villéger, Gwenaëlle Roche, Binta Diémé, Michael Rodrigues, Charline Juban, Marie Lagrée, Nicolas Venisse, Cyril Jousse, Nicolas Barnich et al. · 2025 · Gut Microbes
74. Discovery of potent natural product higenamine derivatives as novel Anti-Fusobacterium nucleatum agents
    Sijia Su, Qingwei Bu, Xuexin Bai, Yahui Huang, Fangfang Wang, Jie Hong, Jing‐Yuan Fang, Shanchao Wu, Chunquan Sheng · 2023 · Bioorganic Chemistry
75. Structural study on human microbiome-derived polyketide synthases that assemble genotoxic colibactin
    Minjae Kim, Jinwoo Kim, Gyu Sung Lee, Paul Dominic B. Olinares, Yougant Airan, Jasmine L. Chow, Jongseok Park, Yujin Jeong, Jiho Park, Brian T. Chait et al. · 2025 · Structure
76. Microbiome and the Hallmarks of Cancer
    Rachel M. Bleich, Janelle C. Arthur · 2021 · Physiology in health and disease
77. Immunomodulatory properties of CNF1 toxin from E. coli: implications for colorectal carcinogenesis.
    Alessia Fabbri, Laura Bracci · 2022 · PubMed Central
78. Colonization of the gut mucosa of colorectal cancer patients by pathogenic mucosa-associated Escherichia coli strains
    Roghayeh Nouri, Alka Hasani, Kourosh Masnadi Shirazi, Fatemeh Yeganeh Sefiadn, Fariba Naeimi Mazraeh, Simin Sattarpour, Mohammad Ahangarzadeh Rezaee · 2024 · Diagnostic Microbiology and Infectious Disease
79. Molecular epidemiology, antibiotic resistance profile and frequency of integron 1 and 2 in adherent-invasive Escherichia coli isolates of colorectal cancer patients
    Aida Heidari, Mohammad Hassan Emami, Fatemeh Maghool, Samane Mohammadzadeh, Parisa Kadkhodaei Elyaderani, Tahereh Safari, Alireza Fahim, Razie Kamali Dolatabadi · 2024 · Frontiers in Microbiology
80. Structure elucidation of colibactin
    Mengzhao Xue, Chung Sub Kim, Alan R. Healy, Kevin M. Wernke, Zhixun Wang, Madeline C. Frischling, Emilee E. Shine, Weiwei Wang, Seth B. Herzon, Jason M. Crawford · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
81. Selection, Comparative Genomics, and Potential Probiotic Features of Escherichia coli 5C, a pks-Negative Strain Isolated from Healthy Infant Donor Feces
    Di Pierro, Francesco, Sagheddu, Valeria, Galletti, Serena, Casaroli, Alice, Labrini, Edoardo, Soldi, Sara, Cazzaniga, Massimiliano, Bertuccioli, Alexander, Matera, Mariarosaria, Cavecchia, Ilaria et al. · 2026 · Probiotics and Antimicrobial Proteins
82. Screening method toward ClbP-specific inhibitors
    Tao Zhou, Takayuki Ando, Akihiro Kudo, Michio Sato, Noriyuki Miyoshi, Michihiro Mutoh, Hideki Ishikawa, Keiji Wakabayashi, Kenji Watanabe · 2023 · Genes and Environment
83. L-tryptophan and copper interactions linked to reduced colibactin genotoxicity in pks+ Escherichia coli
    Charlie F. Bayne, Magali Boutard, Tom Zaplana, Andrew C. Tolonen · 2024 · mSystems
84. Phenotypic characterization and complete genome of a tumorigenic pathobiont Escherichia coli LI60C3
    Linda Chia‐Hui Yu, Shu‐Chen Wei, Yi-Hsuan Li, Chung‐Yen Huang, Yu-Chen Pai, Yuan-Mao Hung, Liang‐Chuan Lai, Yen‐Hsuan Ni · 2025 · Gut Pathogens
85. Infectious Carcinogens Derived from Intestinal Microflora: Mechanisms of Microbial Transitions from Eubionts to Pathobionts
    Yu-Chen Pai, Chung‐Yen Huang, Li-Yu Lin, Yi-Hsuan Li, Linda Chia‐Hui Yu · 2025 · Journal of physiological investigation.
86. Role of Gut Microbiota in Predisposition to Colon Cancer: A Narrative Review
    Hattiangadi Shruthi Kamath, Rushikesh K Shukla, Urmil Shah, Siddhi D. Patel, Soumyajit Das, Ayush Chordia, S Poorvikha, Dibyankita Ghosh · 2024 · Indian Journal of Microbiology
87. Advancements in Understanding and Preventing Obesity-Related Colon Cancer
    Christine Shieh, Henry J. Thompson, Eric M. McLaughlin, Chien‐Wei Chiang, Hisham Hussan · 2024 · The Cancer Journal
88. Genome-scale CRISPR/Cas9 screening reveals the role of PSMD4 in colibactin-mediated cell cycle arrest
    Michael W. Dougherty, Ryan M. Hoffmann, Maria C. Hernandez, Yougant Airan, Raad Z. Gharaibeh, Seth B. Herzon, Ye Yang, Christian Jobin · 2025 · mSphere
89. Insights Into the Relationship Between Gut Microbiota and Colorectal Cancer
    João Felipe Mota, Jens Walter, Carla Marques Maia Prado · 2018 · Current Colorectal Cancer Reports
90. Colibactin mutational signatures in NTHL1 tumor syndrome and MUTYH associated polyposis patients
    D. Terlouw, Arnoud Boot, Quinten R. Ducarmon, Sam Nooij, M. A. Jessurun, Monique Esther van Leerdam, Carli M.J. Tops, Alexandra M. J. Langers, Hans M. Morreau, Tom van Wezel et al. · 2023 · Genes Chromosomes and Cancer
91. Community-Acquired Escherichia coli Bacteremia after Age 50 and Subsequent Incidence of a Cancer Diagnosis: A Danish Population–Based Cohort Study
    Kirstine K. Søgaard, Katalin Veres, Christina M. J. E. Vandenbroucke‐Grauls, Jan Paul Vandenbroucke, Henrik Toft Sørensen, Henrik Carl Schønheyder · 2020 · Cancer Epidemiology Biomarkers & Prevention
92. The Microbiome: the Link to Colorectal Cancer and Research Opportunities
    Samuel H. Cass, Nadim J. Ajami, Michael Geoffrey White · 2022 · Current Treatment Options in Oncology
93. An overview of cancer and the human microbiome
    Soumendu Mahapatra, Smrutishree Mohanty, Rasmita Mishra, Punit Prasad · 2022 · Progress in molecular biology and translational science
94. Microbiome and Diseases: Colorectal Cancer
    Amina Iftekhar, Andreas Sperlich, Klaus‐Peter Janssen, Michael J. Sigal · 2018 · Springer eBooks
95. Analyzing the Secretome of Gut Microbiota as the Next Strategy For Early Detection of Colorectal Cancer
    Putri Intan Hafizah Megat Mohd Azlan, Siok‐Fong Chin, Teck Yew Low, Hui‐min Neoh, Rahman Jamal · 2018 · PROTEOMICS
96. Erratum for Wallenstein et al., “ClbR Is the Key Transcriptional Activator of Colibactin Gene Expression in Escherichia coli”
    Alexander Wallenstein, Nadine Rehm, Marina Brinkmann, Martina Selle, Nadège Bossuet‐Greif, Daniel Sauer, Boyke Bunk, Cathrin Spröer, Haleluya Tesfaye Wami, Stefan Homburg et al. · 2020 · mSphere
97. It Is Time to Consider the Lost Battle of Microdamaged Piezo2 in the Context of E. coli and Early-Onset Colorectal Cancer
    Balázs Sonkodi · 2025 · International Journal of Molecular Sciences
98. Antibiotics, the microbiome and gastrointestinal cancers: A causal interference?
    Daryl Ramai, Massimiliano Salati, Giulia Pomati, Chiara Amoroso, Antonio Facciorusso, Andrea Botticelli, Michele Ghidini · 2022 · Current Opinion in Pharmacology
99. Association between physical activity and the prevalence of tumorigenic bacteria in the gut microbiota of Japanese adults: a cross-sectional study
    Chiharu Iwasaka, Yuka Ninomiya, Takashi Nakagata, Hinako Nanri, Daiki Watanabe, Harumi Ohno, Kumpei Tanisawa, Kana Konishi, Haruka Murakami, Yuta Tsunematsu et al. · 2023 · Scientific Reports
100. Epidemiologic Factors in Relation to Colorectal Cancer Risk and Survival by Genotoxic Colibactin Mutational Signature
     Claire Elizabeth Thomas, Peter Georgeson, Conghui Qu, Robert S. Steinfelder, Daniel D. Buchanan, Mingyang Song, Tabitha A. Harrison, Caroline Y. Um, Meredith A.J. Hullar, Mark A. Jenkins et al. · 2024 · Cancer Epidemiology Biomarkers & Prevention